A.P. Moller - Maersk has announced the signing of a logistics agreement with Novo Nordisk, effective from 2021.
The three-year agreement on cold chain logistics covers transportation, including ocean services and inland logistics.
Maersk - Novo Nordisk partnership
We are proud to be chosen as one of Novo Nordisk´s main logistic companies"
Vincent Clerc, the Executive Vice President (EVP) and Chief Executive Officer (CEO) - Ocean and Logistics, at A.P. Moller – Maersk, said “We are proud to be chosen as one of Novo Nordisk´s main logistic companies. Transporting pharmaceuticals on a global level is a demanding task, with various complexities that require flexible and resilient supply chains, as well as digital and eco-friendly solutions.”
Vincent Clerc adds, “This achievement showcases the rapid transformation of A.P. Moller - Maersk as a modern end-to-end logistics company, with fully controlled assets.”
A.P. Moller - Maersk’s ECO Delivery
One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen A.P. Moller - Maersk’s ECO Delivery to reduce the carbon footprint in transportation.
The initiative uses sustainable biofuel to power selected Maersk vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals. The global agreement will come into effect as of 1st April 2021.
Achieving zero environmental impact
Rune Sylow, Corporate Vice President, Strategic Sourcing, at Novo Nordisk, said “Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business. We consider A.P. Moller - Maersk to be the right global distribution partner, to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”
